In a retrospective cohort study, Tamás Kassai, MD, and colleagues analyzed data on 24 children (mean age of 12.3 years at the time of injury) who received biodegradable implants (ActivaPin, Bioretec) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback